Intensive glucose lowering in cardiovascular risk management - unsolved questions -

Circ J. 2012;76(3):593-5. doi: 10.1253/circj.cj-12-0062. Epub 2012 Jan 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Coronary Artery Disease / prevention & control*
  • Cyclohexanes / pharmacology*
  • Diabetes Mellitus / drug therapy*
  • Female
  • Glycemic Index / drug effects*
  • Humans
  • Inositol / analogs & derivatives*
  • Inositol / pharmacology
  • Male
  • Nateglinide
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / pharmacology

Substances

  • Cyclohexanes
  • Nateglinide
  • Phenylalanine
  • Inositol
  • voglibose